MAM
Mudra’s Interact Vision bags Khaitan home appliances account
MUMBAI: Mudra Group’s creative agency, Interact Vision, has bagged the creative duties for Khaitan home appliances, which includes lights, switchgears, wires and cables.
The account, which is pegged at Rs 30 – 40 million, will be handled out of Kolkata. The incumbent agency for these businesses was JWT Kolkata.
Mudra group business director Kaustuv Bhadra said, “We are extremely pleased with the win. It’s great to know that Khaitan home appliances has entrusted Interact Vision for its brand building activities of its newly diversified business. The win has reaffirmed the group’s capabilities as a truly integrated agency.”
“Our offering Interact Vision as a specialised offering in the Kolkata market is bearing fruit. Khaitan is a creditworthy win, we have more projects lined up for the IV specialized creative cell,” added Mudra and Interact Vision president Hemant Misra.
Until now, the Khaitan name has been synonymous with quality fans in India. Now, Khaitan is diversifying even further. It has added pumps, lights, home appliances, cables, wires and circuit breakers to its portfolio.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
